LDS/Medical Tests/Inhibitor Screen (1:1 Mix), Mixing Studiesa (aPTT mixing study panel)

Inhibitor Screen (1:1 Mix), Mixing Studiesa (aPTT mixing study panel)

This test is useful for evaluating a prolonged activated Partial Thromboplastin Time (aPTT) and Prothrombin Time (PT). The patient's plasma is mixed with pooled normal plasma (1:1 mix) and an aPTT is performed. If the patient has a factor deficiency, the post-mixing aPTT will be normal (correction) and remain normal after a two-hour incubation. If an inhibitor is present, the post-mixing aPTT will still be prolonged (no correction) immediately and/or after incubation. If the aPTT is initially normal after the mixing and then becomes prolonged after one or two hours of incubation, this is characteristic of a factor VIII inhibitor. Some laboratories use the thrombin time if heparin is suspected. The thrombin time is very sensitive to Heparin. Because of this, if the thrombin time is normal the prolonged aPTT cannot be associated with heparin. Factor inhibitors that affect the PT and not the aPTT are very rare; however, PT mixing studies can be similarly performed to evaluate PT prolongations. This test is therefore useful for evaluation of a prolonged PT or aPTT when a factor deficiency or inhibitor is suspected, as might be seen in bleeding disorders such as thrombophilia and other clotting disorders.

  • Evaluation of a prolonged PT or aPTT when a factor deficiency or inhibitor is suspected
  • Diagnosis of bleeding disorders
  • As an aid in diagnosis of thrombophilia and other clotting disorders
  • In conjunction with other clotting factors can be used as an aid in evaluation of certain pregnancy complications, recurrent abortion, and early pregnancy termination

Abnormal (prolonged) result after mixing in:

  • Antiphospholipid antibodies
  • Lupus anticoagulant antibody
  • Factor-specific antibodies
  • Presence of heparin and high dose danaparoid

Normal result after mixing in:

  • Factor deficiencies
  • Some inherited clotting factor mutations

Prothrombin Time (PT) varies among reagents and instruments. Usually the lower limit of normal is 10 - 12 seconds and the upper limit would be 12 - 14.

Newborns can range up to approximately 16 seconds from birth to the age of six months. PT then begins to decrease to the normal adult range.

Activated Partial Thromboplastin Time (aPTT) varies among reagents and instruments. Usually the lower limit of normal is 20 - 25 seconds and the upper limit would be 32 - 39.

Newborns can range up to approximately 55 seconds from birth to the age of six months. aPTT then begins to decrease to the normal adult range.

Prothrombin Time (PT) is performed by adding a reagent, normally thomboplastin, to the patient’s plasma and measuring the number of seconds it takes for a clot to develop. Measurements are taken by optical or mechanical means. Activated Partial Thromboplastin Time (aPTT) is performed by adding aPTT reagent and calcium reagent to the patient’s plasma and measuring the number of seconds it takes for a clot to develop. Measurements are taken by optical or mechanical means.

Plasma Citrate (Light Blue).

Separate Plasma and freeze immediately. Maintain frozen until testing.

Stability

  • Ambient: Unacceptable
  • Refrigerated: Unacceptable
  • Frozen: 14 days
Specific Factor Inhibitor Assay, Thrombin Time, Antiphospholipid Antibody, Lupus anticoagulant, High Molecular Weight Kininogen, Coagulation Testing by Endpoint Methodology, Factor V Leiden, Factor II Mutation, dilute Russell's viper venom time, Keolin clotting time.
Usually same day.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Automated mixing studies and pattern recognition for the laboratory diagnosis of a prolonged activated partial thromboplastin time using an automated coagulation analyzer. Thromb Res. 2011 Jul;128(1):86-91. [PMID: 21397297]
  • Anderson SC, Cockayne S. Clinical Chemistry: concepts and applications. Philadelphia. W.B. Saunders Company (1993).
  • Jacobs DS, DeMott WR. Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc (2001).
  • Pathology Service, retrieved Jan 30, 2010 from: http://www2.massgeneral.org/pathology/coagbook/handbook.htm
  • Arch Pathol Lab Med. 1993 Jun;117(6):595-601. [PMID: 8503730]